✦ LIBER ✦

A case of polymyositis in a chronic hepatitis C patient treated with peg-interferon-alpha 2b and ribavirin therapy

✍ Scribed by Yusuke Okuma; Kiminori Kimura; Shunichi Saeki; Tsunekazu Hishima; Seishu Hayashi

Book ID: 107648924
Publisher: Springer Japan
Year: 2009
Tongue: English
Weight: 244 KB
Volume: 2
Category: Article
ISSN: 1865-7257
DOI: 10.1007/s12328-009-0101-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adverse skin reactions due to pegylated

Adverse skin reactions due to pegylated interferon alpha 2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus

✍ Yuki HASHIMOTO; Hiromi KANTO; Masatoshi ITOH 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 1023 KB

Cost–utility analysis of different peg-i

Cost–utility analysis of different peg-interferon alpha-2b plus ribavirin treatment strategies as initial therapy for naïve Chinese patients with chronic hepatitis C

✍ W.-A. LIN; Y.-H. TARN; S.-L. TANG 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

Prevalence and impact of occult hepatiti

Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin

✍ Marion Levast; Sylvie Larrat; Marie-Ange Thelu; Sandrine Nicod; Agnès Plages; Al 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

## Abstract The prevalence of occult hepatitis B, defined by absence of HBsAg and HBV DNA, ranges widely in patients with hepatitis C. This may influence the treatment of hepatitis C and the severity of liver disease. Sensitive and specific real‐time PCR techniques are available commercially and ca

r-interferon alfa–2b/ribavirin combined

r-interferon alfa–2b/ribavirin combined therapy followed by low-dose r-Interferon alfa-2b in chronic hepatitis C interferon nonresponders

✍ A. Perasso; G. Testino; F. Ansaldi; V. Venturino; G.C. Icardi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 30 KB 👁 2 views

Blood cell, liver function, and response

Blood cell, liver function, and response changes by PEG-interferon-α2b plus ribavirin with polaprezinc therapy in patients with chronic hepatitis C

✍ Ke Ih Kim; Soo Ryang Kim; Noriko Sasase; Yoko Akimoto; Mao Shikata; Aya Ohtani; 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 294 KB

Vitiligo associated with pegylated inter

Vitiligo associated with pegylated interferon and ribavirin treatment of patients with chronic hepatitis C: A case report

✍ Krzysztof Tomasiewicz; Romana Modrzewska; Grażyna Semczuk 📂 Article 📅 2006 🏛 Springer Healthcare Communications 🌐 English ⚖ 201 KB